A new generation of induced pluripotent stem cells for regenerative medicine

Dr Schrepfer and Dr Deuse conducting their stem cell research

Embryonic stem cells or induced pluripotent stem cells are unlimited sources for the generation of cell derivatives for the regeneration of failing organs. However, such cell transplants are subject to immune rejection by the recipient’s immune system. Drs Sonja Schrepfer and Tobias Deuse from the University of California, San Francisco, have developed a new generation of immune-edited induced pluripotent stem […]

Read More… from A new generation of induced pluripotent stem cells for regenerative medicine